Protara Therapeutics, Inc.
NASDAQ:TARA
2.59 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||
Current Assets: | ||||||||||
Cash & Cash Equivalents
| 39.586 | 24.127 | 35.724 | 168.598 | 6.181 | 19.371 | 21.17 | 36.392 | 40.031 | 68.84 |
Short Term Investments
| 25.994 | 60.243 | 55.505 | 0 | 0 | 2.496 | 20.971 | 4.925 | 25.232 | 14.755 |
Cash and Short Term Investments
| 65.58 | 84.37 | 91.229 | 168.598 | 6.181 | 21.867 | 42.141 | 41.317 | 65.263 | 83.595 |
Net Receivables
| 0.242 | 0.486 | 0.634 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 1.163 | 1.215 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 2.883 | 0.127 | 0.034 | 0.787 | 0.744 | 1.369 | 1.339 | 1.438 | 1.345 | 1.006 |
Total Current Assets
| 68.705 | 86.146 | 93.112 | 169.435 | 6.975 | 23.236 | 43.48 | 42.755 | 66.608 | 84.601 |
Non-Current Assets: | ||||||||||
Property, Plant & Equipment, Net
| 6.56 | 7.869 | 8.89 | 1.24 | 0.459 | 0.263 | 0.259 | 0.372 | 0.224 | 0.083 |
Goodwill
| 0 | 0 | 29.517 | 29.517 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 29.517 | 29.517 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 29.517 | 29.517 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0.745 | 17.886 | 39.467 | 0.745 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | -0.745 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 2.944 | 1.389 | 1.61 | 2.965 | 0.122 | 0.022 | 0.24 | 0.393 | 0.706 | 0.114 |
Total Non-Current Assets
| 10.249 | 27.144 | 79.484 | 33.722 | 0.581 | 0.285 | 0.499 | 0.765 | 0.93 | 0.197 |
Total Assets
| 78.954 | 113.29 | 172.596 | 203.157 | 6.975 | 23.521 | 43.979 | 43.52 | 67.538 | 84.798 |
Liabilities & Equity: | ||||||||||
Current Liabilities: | ||||||||||
Account Payables
| 2.434 | 1.586 | 0.954 | 0.914 | 0.263 | 0.441 | 0.008 | 0.556 | 1.02 | 0.917 |
Short Term Debt
| 0.983 | 0.917 | 0.855 | 0.088 | 0 | 0 | 0.02 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0.041 | 0.159 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | -0.028 | 0 | 0 | 0 |
Other Current Liabilities
| 2.732 | 3.237 | 2.489 | 1.913 | 0.32 | 2.637 | 9.24 | 4.523 | 3.113 | 1.421 |
Total Current Liabilities
| 6.149 | 5.74 | 4.298 | 2.915 | 0.583 | 3.078 | 9.24 | 5.079 | 4.133 | 2.338 |
Non-Current Liabilities: | ||||||||||
Long Term Debt
| 4.484 | 5.467 | 6.384 | 0.999 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 4.484 | 5.467 | 6.384 | 0.999 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities
| 10.633 | 11.207 | 10.682 | 3.914 | 0.583 | 3.078 | 9.24 | 5.079 | 4.133 | 2.338 |
Equity: | ||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 18.463 | 21.523 | 21.523 | 0.548 | 0 | 84.798 |
Common Stock
| 0.011 | 0.011 | 0.011 | 0.011 | 0.003 | 0.019 | 0.018 | 0.017 | 0.016 | 0.016 |
Retained Earnings
| -200.384 | -159.964 | -94.012 | -46.76 | -225.462 | -210.47 | -189.741 | -159.777 | -131.251 | -109.874 |
Accumulated Other Comprehensive Income/Loss
| -0.031 | -0.688 | -0.211 | 0 | 0.003 | 0.005 | -0.014 | -0.565 | -0.011 | -0.012 |
Other Total Stockholders Equity
| 268.725 | 262.724 | 256.126 | 245.992 | 213.385 | 209.366 | 202.953 | 198.218 | 194.651 | 107.532 |
Total Shareholders Equity
| 68.321 | 102.083 | 161.914 | 199.243 | 6.392 | 20.443 | 34.739 | 38.441 | 63.405 | 82.46 |
Total Equity
| 68.321 | 102.083 | 161.914 | 199.243 | 6.392 | 20.443 | 34.739 | 38.441 | 63.405 | 82.46 |
Total Liabilities & Shareholders Equity
| 78.954 | 113.29 | 172.596 | 203.157 | 6.975 | 23.521 | 43.979 | 43.52 | 67.538 | 84.798 |